Effects of Physical Therapy on Low Back Pain, Disc Height Index, Postural Stability, Disability, Gait and Function in Persons With Postero-lateral Disc Herniation

NCT ID: NCT06534593

Last Updated: 2024-08-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ENROLLING_BY_INVITATION

Clinical Phase

NA

Total Enrollment

42 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-08-07

Study Completion Date

2025-02-07

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The current study aims to determine if physical therapy is significantly superior in improving postural stability, pain and function and disc height index in persons with discogenic low back pain, as compared to the standardized medical treatment.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Herniation, Disc Low Back Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

the study will consist of 2 arms.
Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control Group

The Control group will receive standard treatment for the management of discogenic low back pain.

Group Type ACTIVE_COMPARATOR

Standard medical treatment

Intervention Type OTHER

Standard medical treatment

Experimental Group

The Physical Therapy group will receive Physical Therapy for the management of discogenic low back pain.

Group Type EXPERIMENTAL

Lumbar Traction

Intervention Type DEVICE

Lumbar traction using traction table

Mckenzie Extension Protocol

Intervention Type OTHER

Mckenzie Extension Exercises

Interferential Therapy

Intervention Type DEVICE

Interferential Therapy for 20 minutes

Heat Therapy

Intervention Type DEVICE

Heat Therapy for 20 minutes

Sustained Natural Apophyseal Glides (SNAGs)

Intervention Type OTHER

3-5 reptations of Mulligan's lumbar extension Sustained Natural Apophyseal Glides (SNAGs)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Standard medical treatment

Standard medical treatment

Intervention Type OTHER

Lumbar Traction

Lumbar traction using traction table

Intervention Type DEVICE

Mckenzie Extension Protocol

Mckenzie Extension Exercises

Intervention Type OTHER

Interferential Therapy

Interferential Therapy for 20 minutes

Intervention Type DEVICE

Heat Therapy

Heat Therapy for 20 minutes

Intervention Type DEVICE

Sustained Natural Apophyseal Glides (SNAGs)

3-5 reptations of Mulligan's lumbar extension Sustained Natural Apophyseal Glides (SNAGs)

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Both male and female participants
* Postero-lateral lumbar disc herniation
* Aged 18-50 years old
* Low back pain intensity less than 80/100mm on visual analogue scale or 8/10 on numeric pain rating scale
* Positive peripheralization and centralization phenomenon

Exclusion Criteria

* Individuals with and any musculoskeletal, metabolic, or neurological disorders that may impair gait, postural stability or sensory integrity will be excluded from the study.
Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Foundation University Islamabad

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Muhammad Osama, PhD*

Role: PRINCIPAL_INVESTIGATOR

Foundation University Islamabad

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Foundation University Islamabad

Islamabad, Federal, Pakistan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Pakistan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FUI/CTR/2024/16

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.